Novartis’ new malaria medicine GanLum at the company’s manufacturing site in Slovenia, October 30, 2024. Novartis/Handout via REUTERS
Novartis’ new malaria medicine GanLum at the company’s manufacturing site in Slovenia, October 30, 2024. Novartis/Handout via REUTERS